Dendreon, Novartis, and Stryker under AAAResearchReports.com Microscope

Wed Jul 17, 2013 8:01am EDT

* Reuters is not responsible for the content in this press release.

Dendreon, Novartis, and Stryker under AAAResearchReports.com Microscope

Editor Note: For more information about this release, please scroll to bottom

PR Newswire

LONDON, July 17, 2013 /PRNewswire/ --

 

On Tuesday, July 16, 2013, shares in healthcare companies ended mostly lower, tracking losses in the broader market which slipped following a mixed batch of economic and earnings reports. Investors also exercised caution ahead of Fed Reserve Chairman Ben Bernanke's semi-annual testimony to Congress on Wednesday. The major movers in the sector included Dendreon Corporation (NASDAQ: DNDN), Novartis AG (ADR) (NYSE: NVS), and Stryker Corporation (NYSE: SYK). AAAResearchReports.com has released full comprehensive research on DNDN, NVS, and SYK. These free technical analyses can be downloaded by signing up at:

http://www.aaaresearchreports.com/register/  

Shares in Dendreon Corporation fell sharply on Tuesday, as the broader market struggled. The company's shares oscillated between $4.50 and $4.68 before finishing the day 1.09% lower at $4.52. A total of 2.76 million shares were traded which is below the daily average volume of 3.46 million. Despite Tuesday's sharp decline, Dendreon's shares have gained 0.89% in the last five trading sessions and 11.60% in the last one month. Nonetheless, in the last three months, the stock has fallen by 0.22%. A free technical analysis on DNDN available by signing up at:

http://www.AAAResearchReports.com/DNDN071713.pdf

Novartis AG's stock ended slightly lower on Tuesday, tracking losses in the broader market. The company's shares ended the day 0.33% lower at $73.47 after fluctuating between $73.27 and $73.64. A total of 1.07 million shares were traded which is below the daily average volume of 1.47 million. Despite Tuesday's pullback, the company's shares are currently trading near their 52-week high of $75.73. The stock has gained 1.14% in the last one month, but has fallen by 0.24% in the past three months. Nonetheless, the stock is currently trading above its 50-above and 200-day moving averages. Register today and access free research on NVS at:

http://www.AAAResearchReports.com/NVS071713.pdf

Shares in Stryker Corporation moved higher on Tuesday, extending their gains from previous trading sessions. The company's shares ended the day 0.66% higher at $68.67 after oscillating between $68.35 and $69.30. A total of 1.38 million shares were traded which is above the daily average volume of 1.18 million. The company's shares have gained 1.91% in the last three sessions, 2.17% in the last one month and 5.52% in the last three months. Furthermore, the stock is currently trading near its 52-week high of $70.00. The free report on SYK can be downloaded by signing up now at:

http://www.AAAResearchReports.com/SYK071713.pdf

EDITOR NOTES:

  1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.
  2. Information in this release is fact checked and produced on a best efforts basis and reviewed by a CFA. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
  3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
  4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco@EquityNewsNetwork.com.
  5. For any urgent concerns or inquiries, please contact us at compliance@EquityNewsNetwork.com.
  6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research@EquityNewsNetwork.com for consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider has, through Chartered Financial Analysts, only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE

Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Equity News Network is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Equity News Network whatsoever for any direct, indirect or consequential loss arising from the use of this document. Equity News Network expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Equity News Network does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

SOURCE AAA Research Reports

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.